Patent Term Extension Application for WINLEVI® (clascoterone), U.S. 9,486,458 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2022-E-2244

Patent Term Extension Application for WINLEVI® (clascoterone), U.S. 9,486,458

Documents

Comments

Description

OPEN

Comment Period OpensSep 15, 2022

Comment Period ClosesApr 16, 2024

Type	Title	Posted	Comments	Status
Other	Letter from FDA CDER to U.S. Patent and Trademark Office	Apr 21, 2026	--

Patent Term Extension

WINLEVI® (clascoterone), U.S. 9486458

Sterne, Kessler, Goldstein & Fox P.L.L.C.

CDER

OPEN